Timothy Scannell, President & COO at Stryker, holds 35.59K shares in Insulet (Ticker: PODD), holds 7.98K shares in NovoCure (Ticker: NVCR), holds 5.69K shares in Exact Sciences (Ticker: EXAS). Most recently, Timothy Scannell Sold ― shares of Insulet on Jun 11, 2024 for an estimated value of 1.33M.